Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00382486 · ClinicalTrials.gov registry record
Low Dose Irradiation for Small Bowel Transplant
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 100
- Enrollment target
NCT00382486 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 100 participants.
The verdict
NCT00382486 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
The specific aims of this study is to improve short and long-term patient and graft survival, to reduce the incidence and severity of allograft rejection, to reduce the incidence of infection and to reduce and/or eventually eliminate the need for long-term immunosuppression.
Interventions
- PROCEDURE Reduce the risk of allograft rejection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2001-07 |
| Est. Completion | 2003-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00382486
The ClinicalTrials.gov registry entry for NCT00382486 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Reduce the risk of allograft rejection is the first listed.
NCT00382486 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00382486 about?
NCT00382486 is a clinical study titled "Low Dose Irradiation for Small Bowel Transplant". The specific aims of this study is to improve short and long-term patient and graft survival, to reduce the incidence and severity of allograft rejection, to reduce the incidence of infection and to reduce and/or eventually eliminate the need for long-term immunosuppression.
What is the current status of trial NCT00382486?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2001-07. Estimated completion is 2003-09.
What interventions are being tested in trial NCT00382486?
The interventions under investigation include: Reduce the risk of allograft rejection (PROCEDURE).
Who is sponsoring clinical trial NCT00382486?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.